USgHIFUa: a listed Operation at public hospitals

and available at Cornwall Medical in the private sector

HONG KONG, Nov. 13, 2023 /PRNewswire/ — “High intensity focused ultrasound ablation of lesion of uterus using ultrasound guidance” has been included as an “Operation” categorized under “INTERMEDIATE II” on the “List of Private Services”[i] published by the Hospital Authority (“HA”) that manages all public hospitals in Hong Kong.

With a debut international installation at the Churchill Hospital of the Oxford University Hospitals NHS Foundation Trust in 2002[ii], followed by CE mark for entering the EU, the first Ultrasound-guided High Intensity Focused Ultrasound ablation (“USgHIFUa”) by Haifu® landed Hong Kong in 2006[iii]: The Department of Obstetrics and Gynaecology of The University of Hong Kong commenced research of USgHIFUa from 2012[iv], and has since 2016 introduced High Intensity Focused Ultrasound for the management of uterine fibroids at Queen Mary Hospital[v], a public hospital under HA’s management.

In the private sector, the same USgHIFUa for uterine fibroids and/or adenomyosis is available as a day surgery at Cornwall Non-Invasive Surgery Centre – Tsim Sha Tsui, a licensed Day Procedure Centre[vi] located at Rm 503-505, 5/F, H Zentre, 15 Middle Road, TST, Kowloon.

“High intensity focused ultrasound: thyroid, uterus, prostate” is listed in the “Nomenclatures of procedures and operations promulgated by Colleges of the Hong Kong Academy of Medicine”[vii]. The Hong Kong College of Obstetricians and Gynaecologists started covering “High intensity / focused ultrasound therapy” in its 5-yearly OG Audit from the 2014 edition[viii].

About Cornwall Medical Group:

Cornwall Non-Invasive Surgery Centre – Tsim Sha Tsui is a Private Healthcare Facility registered by the Department of Health with a Day Procedure Centre Licence (PHF No.: DP000274).

[i]       LIST OF PRIVATE SERVICES, Hospital Authority, Hong Kong. Available at 
https://www3.ha.org.hk/fnc/Operations.aspx?lang=ENG&searchkeyword=high%20intensity. Last accessed on 1 Nov 2023.

[ii]       Ishika Prachee, Feng Wu & David Cranston (2021), Oxford’s clinical experience in the development of high intensity focused ultrasound therapy, International Journal of Hyperthermia, 38:2, 81-88, DOI: 10.1080/02656736.2021.1899311. Last accessed on 1 Nov 2023.

[iii]      港大獲贈超聲治療機 治癌免開刀, 香港文匯報, 2006-11-21. Available at http://paper.wenweipo.com/2006/11/21/HK0611210049.htm. Last accessed on 1 Nov 2023. 

[iv]      Cheung VYT, Ng VWY, The Development of High-Intensity Focused Ultrasound for Fibroids and Adenomyosis in Hong Kong, Hong Kong Medical Diary – Obstetrics & Gynaecology, Federation of Medical Societies of Hong Kong, Vol.27 No.8 Aug 2022, Pg 17-20. Available at https://fmshk.com.hk/database/hkmd/mdaug2022.pdf. Last accessed on 1 Nov 2023.

[v]       Obstetrics and Gynaecology, under “General Gynaecology”, Queen Mary Hospital, Hong Kong. Available at https://www8.ha.org.hk/QMH/services/clinical_department/department/o_g/o_g.aspx. Last accessed on 1 Nov 2023.

[vi]      Private Healthcare Facilities Register, Office for Regulation of Private Healthcare Facilities, Department of Health, Hong Kong. Available at
https://www.directory.orphf.gov.hk/Directory/en/ViewDetail/ViewDetail/RFAwMDAyNzQ=/g. Last accessed on 1 Nov 2023.

[vii]     Nomenclatures of Procedures and Operations Promulgated by Colleges of the Hong Kong Academy of Medicine, Guidelines and Information for Medical Practitioners, The Medical Council of Hong Kong, Pg 22: RA 1489.
Available at https://www.mchk.org.hk/english/guideline/files/Nomenclatures_by_Colleges_of_the_HKAM.pdf. Last accessed on 1 Nov 2023.

[viii]     Report of the Territory-wide Audit in Obstetrics & Gynaecology (2014), Hong Kong College of Obstetricians and Gynaecologists, Pg 286: K 11. Available at https://www.hkcog.org.hk/hkcog/Download/Territory-wide_Audit_in_Obstetrics_Gynaecology_2014.pdf. Last accessed on 1 Nov 2023.

 

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PR Newswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, PR Newswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.